Conditions: Primary Dyslipidemia Mixed Dyslipidemia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 328
Healthy volunteers: no

Brief summary:
Randomized, double-blind, double-dummy, 12-week, active-controlled study of pitavastatin 4 mg daily(QD) vs. pravastatin 40 mg daily(QD) in subjects with primary hyperlipidemia or mixed dyslipidemia.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: pitavastatin intervention 2: pravastatin
Intervention descriptions: intervention 1: pitavastatin 4 mg once daily (QD) intervention 2: Pravastatin 40 mg once daily (QD)

Protocol document: